IPAFRICEPT
UNII 2N71QUE3NL

Substance Identification & Data

This profile provides standardized clinical and technical data for Ipafricept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2N71QUE3NL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1391727-24-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2N71QUE3NL

CAS Registry Number

1391727-24-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IPAFRICEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C102565

National Cancer Institute reference terminology for clinical and research data.

INN ID

9810

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-113

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ipafricept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IPAFRICEPT

Common Names & Synonyms

FUSION PROTEIN FOR IMMUNE APPLICATIONS (FPIA) COMPRISING HOMO SAPIENS FZD8 (FRIZZLED FAMILY RECEPTOR 8, FRIZZLED-8) EXTRACELLULAR DOMAIN, FUSED WITH HOMO SAPIENS IMMUNOGLOBULIN G1 FC FRAGMENT

IPAFRICEPT [INN]

IPAFRICEPT [USAN]

IPAFRICEPT [WHO-DD]